Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
152M
-
Number of holders
-
238
-
Total 13F shares, excl. options
-
36.7M
-
Shares change
-
+44.2K
-
Total reported value, excl. options
-
$3.62B
-
Value change
-
+$4.05M
-
Put/Call ratio
-
3.04
-
Number of buys
-
99
-
Number of sells
-
-111
-
Price
-
$98.47
Significant Holders of BIO-TECHNE Corp - COMMON STOCK (TECH) as of Q2 2015
260 filings reported holding TECH - BIO-TECHNE Corp - COMMON STOCK as of Q2 2015.
BIO-TECHNE Corp - COMMON STOCK (TECH) has 238 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36.7M shares
of 152M outstanding shares and own 24.11% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (2.51M shares), BROWN CAPITAL MANAGEMENT LLC (2.32M shares), Jackson Square Partners, LLC (1.75M shares), BlackRock Fund Advisors (1.68M shares), FIRST TRUST ADVISORS LP (1.53M shares), JANUS CAPITAL MANAGEMENT LLC (1.49M shares), COLUMBIA WANGER ASSET MANAGEMENT LLC (1.44M shares), Mairs & Power INC (1.38M shares), BLAIR WILLIAM & CO/IL (1.27M shares), and MACQUARIE GROUP LTD (1.17M shares).
This table shows the top 238 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.